 - T2D. Eligible patients will be diagnosed with T2D, with diagnosis for at least 1 year, confirmed by their diabetes clinician or medical record review. Consistent with American Diabetes Association ADA criteria for T2D, participants must have HbA1c A1C of at least 6.5 within the last 6 months. The investigators will exclude patients with A1C9 given that patients in this range will likely have more extreme nonadherence andor require ongoing treatment adjustment, increasing the heterogeneity of this sample for this pilot project. If patients appear otherwise eligible, but do not have an A1C value within 6 months, they will be required to have a baseline A1C value of 6.5-9. 